 | Monter d'un niveau |
Ménard, C., Navarro-Domenech, I., Liu, Z., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Béliveau-Nadeau, D., Helou, J., & Chun, P. (2022). Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 2 pages. Lien externe
Ménard, C., Navarro-Domenech, I., Liu, Z., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Béliveau-Nadeau, D., Helou, J., & Chun, P. (2022). MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 971344 (9 pages). Lien externe
Navarro, I., Joseph, L., Liu, Z., Taussky, D., Delouya, G., Barkati, M., Beauchemin, M.-C., Niazi, T., Berlin, A., Helou, J., Raman, S., Beliveau-Nadeau, D., Kadoury, S., Rink, A., Chung, P., & Menard, C. (mai 2021). Outcomes in focal vs. dose-painted salvage HDR brachytherapy for locally recurrent prostate cancer [Résumé]. World Congress of Brachytherapy. Publié dans Radiotherapy and Oncology, 158. Lien externe
